. "Ilaria Bossi" . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A 25 \u064A\u0646\u0627\u064A\u0631 2017"@ar . . . "Marta Caporale" . . . . . . . . . . . . . "vetenskaplig artikel"@sv . "Ernesto Rossi" . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@en . "10.18632/ONCOTARGET.14810" . . . . . "scientific article published on 25 January 2017"@en . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 2017"@uk . "10" . "Mariantonietta Di Salvatore" . . "Rosa Berenato" . "vedeck\u00FD \u010Dl\u00E1nok"@sk . . . . . . . . "Roberta Mennitto" . . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@ast . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@ast . . . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . . . . . . . . . . . "article cient\u00EDfic"@ca . "28129643" . "16887-16898" . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . . . "videnskabelig artikel"@da . "article scientifique"@fr . "Donatella Guarino" . "Giovanni Schinzari" . "bilimsel makale"@tr . . . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@en . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients."@nl . . . "Michele Basso" . . . "5370008" . . . . . "articolo scientifico"@it . . . . "Concetta Santonocito" . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@en . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@en . . . . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients"@ast . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients."@nl . . "8" . . . . . . . . . . . . "Alessia Mennitto" . . . "wetenschappelijk artikel"@nl . . . . . . . . . . "2017-01-25T00:00:00Z"^^ . . . . . . . . . . . . . . "IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients."@nl . . "Carlo Barone" . . . . . "artigo cient\u00EDfico"@pt . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2017"@ast . . . . . . . . . . . "wissenschaftlicher Artikel"@de . .